Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | CDC25B | P30305 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | S100A4 | P26447 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CES1 | P23141 | 3/20 | 0.47 |
| ▸ | APAF1 | O14727 | 2/20 | 0.47 |
| ▸ | TDP2 | O95551 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | BCHE | P06276 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anthraquinone SCHEMBL8081485 | 0.72 | MEN1 (0.92) | KMT2AMEN1CDC25BMAOAPOLB | |
| SCHEMBL223194 | 0.69 | IDO1 (0.48) | KMT2AMEN1CDC25BMAOAPOLB | |
| Anthraquinone SCHEMBL14943 | 0.67 | MEN1 (1.00) | KMT2AMEN1CDC25BMAOAPOLB | |
| Anthraquinone SCHEMBL29358690 | 0.67 | MEN1 (1.00) | KMT2AMEN1CDC25BMAOAPOLB | |
| Anthraquinone SCHEMBL1901249 | 0.67 | MEN1 (1.00) | KMT2AMEN1CDC25BMAOAPOLB | |
| SCHEMBL577831 | 0.67 | CDC25B (0.58) | KMT2AMEN1CDC25BMAOAPOLB | |
| Anthraquinone SCHEMBL6415478 | 0.65 | MEN1 (0.92) | KMT2AMEN1CDC25BMAOAPOLB | |
| 9,10-Phenanthrenequinone SCHEMBL43050 | 0.65 | MEN1 (1.00) | KMT2AMEN1CDC25BMAOAPOLB | |
| Anthraquinone SCHEMBL10991985 | 0.65 | MEN1 (0.92) | KMT2AMEN1CDC25BMAOAPOLB | |
| Anthraquinone SCHEMBL10905960 | 0.65 | MEN1 (0.92) | KMT2AMEN1CDC25BMAOAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806989-B2 | REDOX SYSTEM BETWEEN RADIATION TRANSPARENT PLATES | BAYER AKTIENGESELLSCHAFT (DE) | 2004-10-19 | — | — | US | claimed |
| US-20030129368-A1 | Redox system between radiation transparent plates | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-10 | — | — | US | claimed |
| US-4983324-A | NONLINEAR OPTICAL MATERIALS AND DISPLAY DEVICE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-01-08 | — | — | US | claimed |
| EP-0308444-A1 | PYRROL 1.2-b]AZINES | MERCK PATENT GmbH (DE) | 1989-03-29 | — | — | EP | claimed |
| WO-1988007702-A1 | PYRROL [1.2-b]AZINES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-10-06 | — | — | WO | claimed |
| EP-2851386-B1 | RESIN COMPOSITION FOR OPTICAL STEREOLITHOGRAPHY | CMET INC (JP) | 2017-08-16 | — | — | EP | disclosed |
| EP-2851386-A1 | RESIN COMPOSITION FOR OPTICAL STEREOLITHOGRAPHY | Cmet Inc. (JP) | 2015-03-25 | — | — | EP | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| CN-100497345-C | 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis | OTSUKA PHARMA CO LTD (JP) | 2009-06-10 | — | — | CN | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| CN-1878777-A | 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis | OTSUKA PHARMA CO LTD (JP) | 2006-12-13 | — | — | CN | disclosed |
| US-20030175616-A1 | Optical recording media; high density writing | LANXESS DEUTSCHLAND GMBH (DE) | 2003-09-18 | — | — | US | disclosed |
| EP-1273006-A1 | USE OF LIGHT-ABSORBING COMPOUNDS IN THE INFORMATION LAYER OF OPTICAL DATA CARRIERS, AND OPTICAL DATA CARRIERS | Bayer Aktiengesellschaft (DE) | 2003-01-08 | — | — | EP | disclosed |
| WO-2001075873-A1 | USE OF LIGHT-ABSORBING COMPOUNDS IN THE INFORMATION LAYER OF OPTICAL DATA CARRIERS, AND OPTICAL DATA CARRIERS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-10-11 | — | — | WO | disclosed |
| US-4983324-A | NONLINEAR OPTICAL MATERIALS AND DISPLAY DEVICE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-01-08 | — | — | US | disclosed |
| EP-0308444-A1 | PYRROL 1.2-b]AZINES | MERCK PATENT GmbH (DE) | 1989-03-29 | — | — | EP | disclosed |
| WO-1988007702-A1 | PYRROL [1.2-b]AZINES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-10-06 | — | — | WO | disclosed |
| US-4358521-A | ELECTROGRAPHY | FUJI PHOTO FILM CO., LTD. (JP) | 1982-11-09 | — | — | US | disclosed |
| US-4241154-A | CHELATE COMPOUNDS, COLOR PHOTOGRAPHY | FUJI PHOTO FILM CO., LTD. (JP) | 1980-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | KMT2A 3324/4885MEN1 4525/4885CDC25B 968/4885 |
| US-20030175616-A1 | Optical recording media; high density writing | RHOA, IK, YTHDF1 | KMT2A 165/4885MEN1 2318/4885CDC25B 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.